Additive prognostic value of gamma-glutamyltransferase in coronary artery disease

International Journal of Cardiology

Volumn 136, Issue 1, 2009, Pages 80-85

  Emdin, Michele ^a   Passino, Claudio ^a,b   Michelassi, Claudio ^a   Donato, Luigi ^a   Pompella, Alfonso ^c   Paolicchi, Aldo ^c  

^a CNR   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

C reactive protein; Coronary artery disease; CRP; Gamma glutamyltransferase; GGT; Prognosis

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 67649888380     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.030     Document Type: Article

References (23)

1. Whitfield J.B. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38 (2001) 263-355
2. Paolicchi A., Emdin M., Ghliozeni E., et al. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 109 (2004) 1440
3. Paolicchi A., Minotti G., Tonarelli P., et al. Gamma-glutamyltranspeptidase-dependent iron reduction and LDL oxidation: a potential mechanism in atherosclerosis. J Invest Med 47 (1999) 151-160
4. Wannamethee G., Ebrahim S., and Shaper G. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all-causes. Am J Epidemiol 142 (1995) 699-708
5. Ruttmann E., Brant L.J., Concin H., Diem G., Rapp K., and Hanno Ulmer H. Gamma-glutamyl transferase as a risk factor for cardiovascular disease mortality: an epidemiologic investigation in a cohort of 163,944 Austrian adults. Circulation 112 (2005) 2130-2137
6. Lee D.S., Evans J.C., Robins S.J., et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk. The Framingham Heart Study. Arterioscler Thromb Vasc Biol 27 (2007) 127-133
7. Meisinger C., Doring A., Schneider A., Lowel H., and for the KORA Study Group. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189 (2006) 297-302
8. Lee D.H., Silventoinen K., Hu G., et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women. Eur Heart J 27 (2006) 2170-2176
9. Emdin M., Passino C., Michelassi C., et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 22 (2001) 1802-1807
10. Vasan R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113 (2006) 2335-2362
11. Dixon W.J., Brown M.B., Engelman L., and Jennrich R.I. BMDP Statistical Software Manual (1990), University of California Press, Berkeley
12. Greiner M. Two-graph receiver operating characteristic (TG-ROC): update version supports optimization of cut-off values that minimise overall misclassification costs. J Immunol Methods 191 (1996) 93-94
13. Eilers P.H., and Marx B.D. Flexible smoothing with P-splines and penalties. Stat Sci 11 (1996) 89-121
14. Libby P., and Theroux P. Pathophysiology of coronary artery disease. Circulation 111 (2005) 3481-3488
15. Jaffe A.S., Babuin L., and Apple F.S. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 48 (2006) 1-11
16. Cipollone F., Iezzi A., Fazia M., et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 108 (2003) 1070-1077
17. Norja S., Nuutila L., Karhunen P.J., and Goebeler S. C-reactive protein in vulnerable coronary plaques. J Clin Pathol 60 (2007) 545-548
18. Emdin M., Pompella A., and Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 112 (2005) 2078-2080
19. Paolicchi A., Emdin M., Passino C., et al. Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 186 (2006) 80-85
20. Pang J.H., Jiang M.J., Chen Y.L., et al. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 97 (1996) 2204-2212
21. Whitfield J.B. Serum gamma-glutamyltransferase and risk of disease. Clin Chem 53 (2007) 1-2
22. Grundy S.M. Gamma-glutamyl transferase: another biomarker for metabolic syndrome and cardiovascular risk. Arterioscler Thromb Vasc Biol 27 (2007) 127-133
23. Karlson B.W., Wiklund O., Hallgren P., Sjölin M., Lindqvist J., and Herlitz J. Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 247 (2000) 449-456